Answer:
Paid -in Excess capital as on December 31, 2021 $124 million
Explanation:
The computation of the amount reported as a additional paid-in capital is shown below
For Jan 1, 8 million × $15 $120 million
For June 3, 2 million × $18 ($36 million)
For December 28, 2 million × $20 $40 million
Paid -in Excess capital as on December 31, 2021 $124 million
<span>How could biotechnology affect your privacy? Biotechnology can be used to perform tests that weren't necessary. If these tests are performed health insurance companies may find issues that weren't presented at the time of insuring them and decide not to insure. Biotechnology is the growing of biological processes for different purposes to manipulate microorganisms int the production of antibiotics and hormones. These technology's are growing and giving more focus on what biotech can do for our country and those suffering from illness and hormone issues. </span>
Answer:
$10,000
Explanation:
We need to find the segment margin of the deparment, which is equal to annual contribution margin minus avoidable fixed costs:
Wallen Corporation
Annual contribution margin $80,000
Annual fixed costs $160,000
Unavoidable fixed costs $90,000
Avoidable fixed costs $70,000
Segment Margin = Annual contribution margin - avoidable fixed costs
= $80,000 - $70,000
= $10,000
Therefore, if the company eliminated this department, it would have a financial advantage of $10,000, equivalent to the deparment's current segment margin.
Answer:
$31.61
Explanation:
In order to determine the amount of interest charged you must first calculate the average daily balance:
average daily balance = [($2,030 x 9) + ($1,450 x 22)] / 31 = $1,618.39
Now we must calculate the daily interest rate:
daily interest rate = 23% / 365 = 0.063%
Finally we multiply the average daily balance times the daily interest rate times the number of days in the billing period:
interest charged = $1,618.39 x 0.063% x 31 days = $31.61
Answer:
in the primary market and usually with the assistance of an investment banker.
Explanation:
Primary markets are ones where newly issues securities are sold. When companies seek to gain capital from investors, they issue securities that can be bought buy investors in exchange for capital.
Investment bankers are usually involved in the sale of securities in the primary markets. They obtain the securities on behalf of the investors.
Primary markets are also called new issues market
